Pulmonary Fibrosis Stem Cell Therapy - Mesenchymal Stem Cell Treatment
MSC therapy for idiopathic pulmonary fibrosis (IPF) and interstitial lung disease. Reduces inflammation, promotes tissue repair, improves lung function and quality of life.
Mesenchymal stem cell therapy targeting pulmonary fibrosis progression and lung tissue regeneration.
- Idiopathic Pulmonary Fibrosis (IPF)
- Interstitial Lung Disease (ILD)
- Post-COVID Lung Fibrosis
- Occupational Lung Disease
- Anti-inflammatory and immunomodulatory effects
- Promotes alveolar tissue repair
- Improves lung function metrics
- Reduces dyspnea and cough symptoms
- Slows disease progression